<?xml version="1.0" encoding="UTF-8"?>
<ref id="B70-pharmaceuticals-13-00303">
 <label>70.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ceci</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Lacal</surname>
    <given-names>P.M.</given-names>
   </name>
   <name>
    <surname>Tentori</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>De Martino</surname>
    <given-names>M.G.</given-names>
   </name>
   <name>
    <surname>Miano</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Graziani</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid</article-title>
  <source>Nutrients</source>
  <year>2018</year>
  <volume>10</volume>
  <elocation-id>1756</elocation-id>
  <pub-id pub-id-type="doi">10.3390/nu10111756</pub-id>
 </element-citation>
</ref>
